Details

Autor(en) / Beteiligte

• Dionne, Janis M., MD
• Harris, Kevin C., MD, MHSc
• Benoit, Geneviève, MD
• Feber, Janusz, MD
• Poirier, Luc, BPharm, MSc
• Cloutier, Lyne, RN, PhD
• Nakhla, Meranda, MD, MSc
• Rabi, Doreen M., MD, MSc
• Daskalopoulou, Stella S., MD, PhD
• Fournier, Anne, MD

Titel

Hypertension Canada's 2017 Guidelines for the Diagnosis, Assessment, Prevention, and Treatment of Pediatric Hypertension

Ist Teil von

• Canadian journal of cardiology, 2017-05, Vol.33 (5), p.577-585

Ort / Verlag

England: Elsevier Inc

Erscheinungsjahr

2017

Quelle

MEDLINE

Beschreibungen/Notizen

• Abstract After the 2016 guidelines for blood pressure measurement, diagnosis, and investigation of pediatric hypertension, we now present evidence-based guidelines for the prevention and treatment of hypertension in children. These guidelines were developed by Hypertension Canada's Guideline Committee pediatric subgroup after thorough evaluation of the available literature. Included are 10 guidelines specifically addressing health behaviour management, indications for drug therapy in children with hypertension, choice of therapy for children with primary hypertension, and goals of therapy for children with hypertension. Although the pediatric literature is inherently limited by small numbers of participants, fewer trials, and a prolonged latency to the development of vascular outcomes, this report reflects the current and highest level of evidence and provides guidance for primary care practitioners on the management of pediatric hypertension. Studies of therapeutic lifestyle modifications in children are available to guide current management and more antihypertensive drugs have been studied in children since the Food and Drug Administration Modernization Act. Consistent with Hypertension Canada's guideline policy, diagnostic and therapeutic algorithm tools will be developed and the guidelines will be reviewed annually and updated according to new evidence.